For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

VU grad wins Fulbright grant Micah Koppang, a 2025 Valparaiso University graduate, has been selected for a Fulbright scholarship. Koppang, a Spanish major with a minor in political science who ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

Iran – A new randomized clinical trial published in Dermatologic Therapy has found that intramuscular pantothenic acid ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...